Clinical Trials Browser

INDUSTRY × Leukemia, Myeloid, Acute × Methods × Clear all

NCT03152526 2020-07-09

CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR

Phase NA Terminated

1 enrolled 5 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute